Research Symposium

Research Symposium: See the Science. Meet the Minds

Each year, the ACPHS Research Symposium celebrates the original research conducted by our students across a wide range of disciplines. This two-day signature event is a unique opportunity for students to showcase their work to classmates, faculty and leaders across the health-sciences industry.

Here’s what you can expect:

• Explore an interactive display of student research posters
• Attend podium presentations led by students and faculty
• Hear from guest speakers at the forefront of their fields
• Connect with the vibrant ACPHS research community

The poster session mirrors the format of a professional academic conference. It features a wide range of student research and provides the opportunity to present through both posters and oral presentations. The next day, faculty take the spotlight—sharing their current research in longer-format talks that allow for deeper discussion and insight into their work. Whether you’re attending virtually or exploring the poster session on campus, you’ll experience the in-depth, innovative student research happening at ACPHS.

2025 Research Symposium

Thursday, April 3 and Friday, April 4

Day 1 – Poster Presentations and Industry-Sponsored Tables

Thursday, April 3

Day 2 – Podium Presentations In-person and virtually

Friday, April 4

Welcoming Remarks by President Toyin Tofade [Image of Toyin Tofade]

Keynote Speaker: Julia Moore Vogel, PhD, MBA

Topic: “Long COVID Research: Best Practices and Future Outlook”

Julia Moore Vogel is a contributor at the Patient Led Research Collaborative and a Senior Program Director at Scripps Research. She is using over four years of lived experience with long COVID and myalgic encephalomyelitis to conduct research that aims to address long COVID and other infection-associated chronic-illness symptoms through efforts such as the Long COVID Wearable Study.

She is also the co-principal investigator for The Participant Center of the All of Us Research Program, overseeing efforts to accelerate medical breakthroughs through an inclusive health research program, and the ImmunoCARE Study, which aims to improve COVID-19 outcomes for immunocompromised individuals. She previously managed genomics initiatives at the New York Genome Center and The Rockefeller University. She has a PhD in computational biology and medicine and an MBA, both from Cornell University.